← SynDRA
DG051
SynDRA canonical compound SYN0573936 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LTA4H |
|---|
| Mechanism of action | leukotriene synthesis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- LTA4H INHIBITOR
- leukotriene synthesis inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- DG-051 free base
- DG051 (free acid)
- T6WM2IY2LM
- DG-051 free base;DG 051 free base
- UNII-T6WM2IY2LM
- SCHEMBL989668
- GTPL6548
- orb1741166
- PVCTYSQBVIGZRU-KRWDZBQOSA-N
- GLXC-23674
- BDBM50303649
- AKOS030525381
- s10044
- HY-10826
- T68314
- 3fh7
- DG-051
- compound 20 [PMID: 19950900]
- orb1296245
- RefChem:132441
- 4-{(S)-2-[4-(4-Chlorophenoxy)phenoxymethyl]pyrrolidin-1-yl}-butyric Acid
- HY-10825
- 4-[(2S)-2-[4-(4-chlorophenoxy)phenoxymethyl]pyrrolidin-1-yl]butanoic acid
- UNII-28B7Y5Y8EF
- CS-6085
- compound 20 (PMID: 19950900)
- (S)-4-(2-((4-(4-chlorophenoxy)phenoxy)methyl)pyrrolidin-1-yl)butanoic acid
- DG-051 HCl
- CHEMBL565789
- Dg 051 (HCl salt)
- SCHEMBL4314376
- UCPVOTSNNAVKNE-LMOVPXPDSA-N
- AKOS030525382
- AS-35044
- 4-[(2s)-2-{[4-(4-Chlorophenoxy)phenoxy]methyl}pyrrolidin-1-Yl]butanoate
- ZINC34884331
- MFCD18251532
- BDBM50294161
- SCHEMBL13809028
Look up DG051 in the interactive SynDRA portal →